Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Calcitonin receptors, bone sialoprotein and osteopontin are expressed in primary breast cancers|
|Citation:||International Journal of Cancer, 1997; 73(6):812-815|
|Matthew T. Gillespie, Rachel J. Thomas, Zhao-Yan Pu, Hong Zhou, T. John Martin, David M. Findlay|
|Abstract:||Several human breast cancer cell lines express the calcitonin receptor (CTR), but this has not been demonstrated previously in clinical breast cancers. We examined 18 primary breast cancers by reverse transcription-PCR, for expression of CTR and of the bone proteins osteopontin (OPN) and bone sialoprotein (BSP). OPN and CTR were expressed by each of the tumours, and 7 (39%) additionally expressed an alternate form of CTR, whilst BSP was expressed by 13 tumours (72%). In situ hybridisation confirmed that expression of OPN and CTR was confined to the tumour cells. Expression of CTR, BSP and OPN may prove to be a useful marker for breast cancers, and their role in the homing of breast cancer cells to bone remains to be investigated.|
|Keywords:||Tumor Cells, Cultured|
Carcinoma, Ductal, Breast
In Situ Hybridization
Polymerase Chain Reaction
|Rights:||© 1997 Wiley-Liss, Inc.|
|Appears in Collections:||Aurora harvest|
Orthopaedics and Trauma publications
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.